Top

Electromagnetic pulses provide pain relief for osteoarthritis

March 5, 2010 by admin · Leave a Comment 

Contact: Maria Seyrig
mseyrig1@hfhs.org
313-874-4039
Henry Ford Health System
Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers.

Read more

New ’suicide’ molecule halts rheumatoid arthritis

January 27, 2010 by admin · Leave a Comment 

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University Read more

Blood test can predict rheumatoid arthritis before symptoms arise

January 27, 2010 by admin · Leave a Comment 

Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell Read more

How arthritis thrives

January 24, 2010 by admin · Leave a Comment 

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University Read more

UT rheumatologists advance genetic research related to disabling form of arthritis

January 9, 2010 by admin · Leave a Comment 

Contact: Meredith Raine
Meredith.Raine@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease. In addition, the international research team pinpointed two areas along stretches of DNA that play an important role in regulating gene activity associated with the arthritic condition.

Read more

Enzyme necessary for development of healthy immune system

December 20, 2009 by admin · Leave a Comment 

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Mice without the deoxycytidine kinase (dCK) enzyme have defects in their adaptive immune system, producing very low levels of both T and B lymphocytes, the major players involved in immune response, according to a study by researchers with UCLA’s Jonsson Comprehensive Cancer Center.

Read more

Biogen Idec’s oral compound BG-12 achieves development milestones in MS and RA

December 6, 2009 by admin · Leave a Comment 

Contact: Tracy Vineis
617-914-6524
GCI Health
CAMBRIDGE, Mass. December 7, 2009 Biogen Idec (NASDAQ: BIIB) today announced that its oral compound BG-12 (dimethyl fumarate) achieved key milestones in clinical trials for multiple sclerosis (MS) and rheumatoid arthritis (RA). In recent months, the last patient was enrolled in the CONFIRM trial, the second of two Phase III trials designed to evaluate the efficacy and safety of BG-12 as a monotherapy in patients with relapsing-remitting multiple sclerosis (RRMS). Both the DEFINE and CONFIRM Phase III trials are now fully enrolled and will evaluate the effect of BG-12 on clinical relapse, disability progression, various MRI measures of disease activity, and safety.

Read more

How saturated fatty acids ‘anger’ the immune system (and how to stop them)

November 3, 2009 by admin · Leave a Comment 

Researchers have new evidence to explain how saturated fatty acids, which soar in those who are obese, can lead the immune system to respond in ways that add up to chronic, low-grade inflammation. The new results could lead to treatments designed to curb that inflammatory state, and the insulin resistance and type 2 diabetes that come with it.

Read more

New biologic drug is effective against rheumatoid arthritis

October 6, 2009 by admin · Leave a Comment 

Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review. The review examines recent trials to assess safety and efficacy of the drug.

Read more

Hormone promises to keep joint injuries from causing long-term osteoarthritis

September 14, 2009 by admin · Leave a Comment 

Goal to extend useful life of arthritic knees and hips

An existing osteoporosis drug is the first ever found to prevent cartilage loss from osteoarthritis following injury to a joint, and may also regenerate some cartilage that has been lost to osteoarthritis, according to an early study presented today at the annual meeting of the American Society for Bone and Mineral Research in Denver. While the study was in mice, the model closely mimics human osteoarthritis that develops following knee injuries, according to the study authors.

Read more

Next Page »

Bottom